Table 3.
Inflammation and platelet biomarkers in the subgroups of ACS patients depending on the sensitivity of signs and symptoms (STEMI, NSTEMI, and UA) compared to controls. Results are presented as medians and interquartile ranges.
| STEMI N = 33 |
NSTEMI N = 30 |
UA N = 30 |
C N = 30 |
P | |
|---|---|---|---|---|---|
| STEMI vs. C | |||||
| NSTEMI vs. C | |||||
| UA vs. C | |||||
| WBC [x103/μL] | 8.70 (7.50–10.00) | 8.05 (7.50–10.00) | 7.65 (5.80–9.50) | 6.31 (5.38–7.35) | 0.0000 |
| 0.0000 | |||||
| 0.0030 | |||||
| CRP [mg/L] | 3.5 (1.4–5.0) | 2.0 (0.9–3.9) | 1.3 (0.9–2.9) | 0.75 (0.5–1.1) | 0.0000 |
| 0.0002 | |||||
| 0.0018 | |||||
| IL-6 [pg/mL] | 12.8 (9.9–17.4) | 18.8 (12.2–24.1) | 5.4 (2.2–11.0) | 7.6 (6.9–8.1) | 0.0001 |
| 0.0000 | |||||
| NS | |||||
| PLT [x103/μL] | 222 (188–273) | 206 (168–254) | 210 (175–223) | 233 (207–250) | NS |
| NS | |||||
| 0.0062 | |||||
| MPV [fL] | 10.9 (10.0–11.5) | 10.9 (10.2–11.2) | 11.1 (10.4–11.3) | 9.4 (9.2–9.8) | 0.000 |
| 0.000 | |||||
| 0.000 | |||||
| β-TG [IU/mL] | 69 (53–118) | 71 (53–128) | 70 (53–95) | 29 (23–33) | 0.000 |
| 0.000 | |||||
| 0.000 |
WBC – white blood cells count, CRP – C-reactive protein, IL-6 – interleukin-6, PLT – platelet count, MPV – mean platelet volume, L-PLT – large platelet, β-TG – β-thromboglobulin, STEMI – ST-segment elevation myocardial infarction, NSTEMI – non-ST-segment elevation myocardial infarction, UA – unstable angina.
Conversion factors to SI units are as follows: for WBC – 1.0, for PLT – 1.0.